Literature DB >> 1700055

A transforming growth factor beta 2 (TGF-beta 2)-like immunosuppressive factor in amniotic fluid and localization of TGF-beta 2 mRNA in the pregnant uterus.

D J Altman1, S L Schneider, D A Thompson, H L Cheng, T B Tomasi.   

Abstract

This report describes a murine amniotic fluid (MAF) immunosuppressive factor that has properties similar to transforming growth factor beta (TGF-beta). The MAF factor exhibits TGF-beta-like activity in stimulating soft agar colony formation by AKR-2B cells and inhibiting thymidine uptake by Mv1Lu cells. We demonstrate that both the immunosuppressive and TGF-beta-like activities of the MAF factor are completely neutralized by anti-TGF-beta 2-specific antibodies and not by anti-TGF-beta 1-specific antisera. The immunosuppressive factor in MAF is novel in that it appears to be identical or very closely related to TGF-beta 2 and is active in its native state. This active and anti-TGF-beta 2-neutralizable factor chromatographs at approximately 70 kD on Sephadex at neutral pH and appears to be able to complex with alpha-fetoprotein in native amniotic fluid. Chromatography of native MAF under acidic conditions demonstrates a lower molecular mass protein that chromatographs on BioGel in the same position as the mature 25-kD TGF-beta. This protein has the biological properties of TGF-beta and is immunosuppressive. Both of these activities are neutralizable with anti-TGF-beta 2 but not with anti-TGF-beta 1 or other antisera. By Northern analysis, we find high levels of TGF-beta 2 mRNA (with little or no TGF-beta 1) in the pregnant uterus that peak around day 15 of gestation and then fall rapidly by day 19 as birth approaches. The TGF-beta 2-like factor could possibly play a role in maternal immunity, in the retention of the fetal allograft, as well as in regulating fetal and neonatal immunological competence.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700055      PMCID: PMC2188670          DOI: 10.1084/jem.172.5.1391

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  58 in total

1.  The transforming growth factor-beta system, a complex pattern of cross-reactive ligands and receptors.

Authors:  S Cheifetz; J A Weatherbee; M L Tsang; J K Anderson; J E Mole; R Lucas; J Massagué
Journal:  Cell       Date:  1987-02-13       Impact factor: 41.582

2.  The suppressive effects of type beta transforming growth factor (TGF beta) on primitive murine hemopoietic progenitors are abrogated by interleukin-6 and granulocyte colony-stimulating factor.

Authors:  K Kishi; L R Ellingsworth; M Ogawa
Journal:  Leukemia       Date:  1989-10       Impact factor: 11.528

3.  Mesoderm induction in amphibians: the role of TGF-beta 2-like factors.

Authors:  F Rosa; A B Roberts; D Danielpour; L L Dart; M B Sporn; I B Dawid
Journal:  Science       Date:  1988-02-12       Impact factor: 47.728

4.  Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness.

Authors:  A H Rook; J H Kehrl; L M Wakefield; A B Roberts; M B Sporn; D B Burlington; H C Lane; A S Fauci
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

5.  Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes.

Authors:  J H Kehrl; A B Roberts; L M Wakefield; S Jakowlew; M B Sporn; A S Fauci
Journal:  J Immunol       Date:  1986-12-15       Impact factor: 5.422

6.  Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation.

Authors:  S M Wahl; D A Hunt; H L Wong; S Dougherty; N McCartney-Francis; L M Wahl; L Ellingsworth; J A Schmidt; G Hall; A B Roberts
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

7.  Isolation and characterization of a distinct immunoregulatory isoform of alpha-fetoprotein produced by the normal fetus.

Authors:  N S van Oers; B L Cohen; R A Murgita
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

8.  Expression of transforming growth factor beta 2 RNA during murine embryogenesis.

Authors:  R W Pelton; S Nomura; H L Moses; B L Hogan
Journal:  Development       Date:  1989-08       Impact factor: 6.868

9.  Tissue specificity of alpha-fetoprotein messenger RNA expression during mouse embryogenesis.

Authors:  M A Dziadek; G K Andrews
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

10.  Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth.

Authors:  J H Kehrl; L M Wakefield; A B Roberts; S Jakowlew; M Alvarez-Mon; R Derynck; M B Sporn; A S Fauci
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307

View more
  14 in total

Review 1.  Latent-TGF-beta: an overview.

Authors:  D A Lawrence
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

2.  Transforming growth factor-beta complexes with thrombospondin.

Authors:  J E Murphy-Ullrich; S Schultz-Cherry; M Höök
Journal:  Mol Biol Cell       Date:  1992-02       Impact factor: 4.138

3.  Macrophage functions are regulated by murine decidual and tumor extracellular matrices.

Authors:  D B McKay; M A Vazquez; R W Redline; C Y Lu
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

4.  Differentiation potential of rat amnion.

Authors:  V Knezevic
Journal:  J Anat       Date:  1996-08       Impact factor: 2.610

Review 5.  Amniotic fluid: Source of trophic factors for the developing intestine.

Authors:  Soham Dasgupta; Shreyas Arya; Sanjeev Choudhary; Sunil K Jain
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

6.  Characterization of transforming growth factor-beta (TGF-beta) receptors on BeWo choriocarcinoma cells including the identification of a novel 38-kDa TGF-beta binding glycoprotein.

Authors:  E J Mitchell; K Lee; M D O'Connor-McCourt
Journal:  Mol Biol Cell       Date:  1992-11       Impact factor: 4.138

7.  Expression of MHC antigens by intestinal epithelial cells. Effect of transforming growth factor-beta 2 (TGF-beta 2).

Authors:  A Donnet-Hughes; E J Schiffrin; A C Huggett
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

8.  The immunomodulatory activity of human amniotic fluid can be correlated with transforming growth factor-beta 1 (TGF-beta 1) and beta 2 activity.

Authors:  A K Lang; R F Searle
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

9.  Transforming growth factor-beta 1 (TGF-beta 1)- and beta 2-like activities in malignant pleural effusions caused by malignant mesothelioma or primary lung cancer.

Authors:  J Maeda; N Ueki; T Ohkawa; N Iwahashi; T Nakano; T Hada; K Higashino
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

10.  Transforming growth factor beta mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium.

Authors:  K L Bruner; W H Rodgers; L I Gold; M Korc; J T Hargrove; L M Matrisian; K G Osteen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.